Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Altered Plasma Levels of Glucagon, GLP-1 and Glicentin During OGTT in Adolescents With Obesity and Type 2 Diabetes
Hannes Manell, Johan Staaf, Levon Manukyan, et al.
The Journal of Clinical Endocrinology & Metabolism (2016) Vol. 101, Iss. 3, pp. 1181-1189
Open Access | Times Cited: 75

Showing 1-25 of 75 citing articles:

Dissecting the Physiology and Pathophysiology of Glucagon-Like Peptide-1
Silvano Paternoster, Marco Falasca
Frontiers in Endocrinology (2018) Vol. 9
Open Access | Times Cited: 65
The Implication of Gut Hormones in the Regulation of Energy Homeostasis and Their Role in the Pathophysiology of Obesity
Chrysi Koliaki, Stavros Liatis, Μaria Dalamaga, et al.
Current Obesity Reports (2020) Vol. 9, Iss. 3, pp. 255-271
Open Access | Times Cited: 62
Prediabetes in youths: mechanisms and biomarkers
Ram Weiss, Nicola Santoro, Cosimo Giannini, et al.
The Lancet Child & Adolescent Health (2017) Vol. 1, Iss. 3, pp. 240-248
Open Access | Times Cited: 56
Basal hypersecretion of glucagon and insulin from palmitate-exposed human islets depends on FFAR1 but not decreased somatostatin secretion
Hörður G. Kristinsson, Ernest Sargsyan, Hannes Manell, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 53
Fasting Plasma GLP-1 Is Associated With Overweight/Obesity and Cardiometabolic Risk Factors in Children and Adolescents
Sara Stinson, Anna Jonsson, Morten Asp Vonsild Lund, et al.
The Journal of Clinical Endocrinology & Metabolism (2021) Vol. 106, Iss. 6, pp. 1718-1727
Open Access | Times Cited: 39
Pediatric Metabolic Syndrome: Pathophysiology and Laboratory Assessment.
Victoria Higgins, Khosrow Adeli
PubMed (2017) Vol. 28, Iss. 1, pp. 25-42
Closed Access | Times Cited: 43
Insights on glicentin, a promising peptide of the proglucagon family
Juliette Raffort, Fabien Lareyre, Damien Massalou, et al.
Biochemia Medica (2017) Vol. 27, Iss. 2, pp. 308-324
Open Access | Times Cited: 40
Basal glucagon hypersecretion and response to oral glucose load in prediabetes and mild type 2 diabetes
Raishi Ichikawa, Koji Takano, Kazumi Fujimoto, et al.
Endocrine Journal (2019) Vol. 66, Iss. 8, pp. 663-675
Open Access | Times Cited: 37
Glucagon‐like peptide‐1 receptor is expressed in human and rodent testis
Rosario Caltabiano, D. F. Condorelli, Salvatore Panza, et al.
Andrology (2020) Vol. 8, Iss. 6, pp. 1935-1945
Open Access | Times Cited: 33
Role of serum fasting glucagon in hypothyroidism-related nonalcoholic fatty liver disease
Mervat M. El-Eshmawy, Amira F. Barakat, Azza A. El-Baiomy, et al.
Nutrition & Metabolism (2025) Vol. 22, Iss. 1
Open Access
Developmental exposure to a very low dose of bisphenol A induces persistent islet insulin hypersecretion in Fischer 344 rat offspring
Levon Manukyan, Linda Dunder, Peter Lind, et al.
Environmental Research (2019) Vol. 172, pp. 127-136
Open Access | Times Cited: 35
Hyperglucagonemia in youth is associated with high plasma free fatty acids, visceral adiposity, and impaired glucose tolerance
Hannes Manell, Hjalti Kristinsson, Joel Kullberg, et al.
Pediatric Diabetes (2019) Vol. 20, Iss. 7, pp. 880-891
Open Access | Times Cited: 33
Postpartum treatment with liraglutide in combination with metformin versus metformin monotherapy to improve metabolic status and reduce body weight in overweight/obese women with recent gestational diabetes: A double-blind, randomized, placebo-controlled study
Karen Elkind‐Hirsch, Donna Shaler, Renee Harris
Journal of Diabetes and its Complications (2020) Vol. 34, Iss. 4, pp. 107548-107548
Closed Access | Times Cited: 30
Circulating levels of proglucagon‐derived peptides are differentially regulated by the glucagon‐like peptide‐1 agonist liraglutide and the centrally acting naltrexone/bupropion and can predict future weight loss and metabolic improvements: A 6‐month long interventional study
Konstantinos Stefanakis, Alexander Kokkinos, Georgia Argyrakopoulou, et al.
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 9, pp. 2561-2574
Open Access | Times Cited: 10
Circulating levels of all proglucagon-derived peptides are differentially regulated postprandially by obesity status and in response to high-fat meals vs. high-carbohydrate meals
Konstantinos Stefanakis, Alexander Kokkinos, Stamatia Simati, et al.
Clinical Nutrition (2023) Vol. 42, Iss. 8, pp. 1369-1378
Closed Access | Times Cited: 9
Response to lowering plasma glucose is characterised by decreased oxyntomodulin: Results from a randomised controlled trial
Yutong Liu, Wandia Kimita, Sakina H. Bharmal, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2024) Vol. 18, Iss. 6, pp. 103052-103052
Open Access | Times Cited: 3
The Role of Glicentin and Oxyntomodulin in Human Metabolism: New Evidence and New Directions
Nikolaos Perakakis, Christos S. Mantzoros
The Journal of Clinical Endocrinology & Metabolism (2020) Vol. 105, Iss. 8, pp. e3003-e3005
Open Access | Times Cited: 25
Oral Glucose Tolerance Test Glucose Peak Time Is Most Predictive of Prediabetes and Hepatic Steatosis in Obese Girls
Melanie Cree‐Green, Danielle Xie, Haseeb Rahat, et al.
Journal of the Endocrine Society (2018) Vol. 2, Iss. 6, pp. 547-562
Open Access | Times Cited: 26
<p>Genistein diet improves body weight, serum glucose and triglyceride levels in both male and female ob/ob mice</p>
Schuyler Rockwood, Daniel M. Mason, Ryan Lord, et al.
Diabetes Metabolic Syndrome and Obesity (2019) Vol. Volume 12, pp. 2011-2021
Open Access | Times Cited: 25
Hepatocyte-specific HIF-1α ablation improves obesity-induced glucose intolerance by reducing first-pass GLP-1 degradation
Yun Sok Lee, Matthew Riopel, Pedro Cabrales, et al.
Science Advances (2019) Vol. 5, Iss. 7
Open Access | Times Cited: 24
Will medications that mimic gut hormones or target their receptors eventually replace bariatric surgery?
Alexander Kokkinos, Dimitrios Tsilingiris, Carel W. le Roux, et al.
Metabolism (2019) Vol. 100, pp. 153960-153960
Closed Access | Times Cited: 24
Biomarkers of Glucose Metabolism Alterations and the Onset of Metabolic Syndrome in Survivors of Childhood Acute Lymphoblastic Leukemia
Katarzyna Konończuk, Katarzyna Muszyńska‐Rosłan, Karolina Konstantynowicz-Nowicka, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3712-3712
Open Access | Times Cited: 13
Gastrointestinal Hormones ☆
Fiona M. Gribble, Frank Reimann, Geoffrey Roberts
Elsevier eBooks (2018), pp. 31-70
Closed Access | Times Cited: 21
Role of enteroendocrine hormones in appetite and glycemia
Maria Laura Ricardo-Silgado, Alison Mcrae, Andrés Acosta
Obesity Medicine (2021) Vol. 23, pp. 100332-100332
Open Access | Times Cited: 15
Methods paper: Performance characteristics of novel assays for circulating levels of proglucagon-derived peptides and validation in a placebo controlled cross-over randomized clinical trial
Nikolaos Perakakis, Bhanu Kalra, Angeliki M. Angelidi, et al.
Metabolism (2022) Vol. 129, pp. 155157-155157
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top